Tae Park Sang
Director/Miembro de la Junta en Oxford Cancer Biomarkers Ltd. .
Perfil
Tae Park Sang is a Non-Executive Director at Oxford Cancer Biomarkers Ltd.
He was previously the Chief Executive Officer at Dx & Vx Co., Ltd.
Cargos activos de Tae Park Sang
| Empresas | Cargo | Inicio |
|---|---|---|
Oxford Cancer Biomarkers Ltd.
 Oxford Cancer Biomarkers Ltd. Hospital/Nursing ManagementHealth Services Oxford Cancer Biomarkers Ltd. provides cancer treatment services. It offers a suite of drug-specific companion diagnostic kits that allow the biomarker to be directly measured in tumor biopsies or patient DNA and thereby patients that respond favorably to the drug identified. The company was founded by David Kerr and Nick LaThangue in 2012 and is headquartered in Oxford, the United Kingdom. | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Tae Park Sang.
| Empresas | Cargo | Fin |
|---|---|---|
| DX & VX CO., LTD. | Director Ejecutivo | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| DX & VX CO., LTD. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Oxford Cancer Biomarkers Ltd.
Oxford Cancer Biomarkers Ltd. Hospital/Nursing ManagementHealth Services Oxford Cancer Biomarkers Ltd. provides cancer treatment services. It offers a suite of drug-specific companion diagnostic kits that allow the biomarker to be directly measured in tumor biopsies or patient DNA and thereby patients that respond favorably to the drug identified. The company was founded by David Kerr and Nick LaThangue in 2012 and is headquartered in Oxford, the United Kingdom. | Health Services |
- Bolsa de valores
- Insiders
- Tae Park Sang
